Omeprazole Capsules
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Logistics Agency (DLA) Troop Support has issued Modification 0005 to contract SPE2D2-24-D-0004 for the procurement of Omeprazole Capsules. This modification exercises the second option year of the contract, extending the period of performance from February 28, 2026, to February 27, 2027.
Scope of Work
The contract involves the supply of Omeprazole in 20 MG and 40 MG dosages. Deliverables include bottles of various counts (30, 90, 100, 500, and 1000). The products are manufactured by Laboratories Liconsa and Towa Pharmaceuticals Europe in Spain, with final packaging and compounding performed by Golden State Medical Supply, Inc. (GSMS) in Camarillo, CA.
Contract & Timeline
- Contract Type: Award Notice / Modification (Firm Fixed-Price/RFP)
- Current Action: Exercise of Option Year 2 (Mod P00005)
- Option Period: February 28, 2026 – February 27, 2027
- Total Adjusted Value: $25,313,710.85 (following a $3.5M reduction in Mod P00001)
- Set-Aside: None specified (Competitive RFP award)
- Awardee: Golden State Medical Supply, Inc.
Recent Modifications
- Modification P00005: Exercises the second option year through February 2027.
- Modification P00003: Exercised the first option year (February 2025 – February 2026).
- Modification P00002: Incorporated FAR 52.204-30 regarding Federal Acquisition Supply Chain Security Act (FASCSA) orders.
- Modification P00001: Decreased the total contract value from $28.8M to $25.3M.
Additional Notes
This notice serves as an administrative update to an existing award. All other terms and conditions of the original contract remain unchanged. The primary point of contact is Courtney Hunter-Stangler.